MINNEAPOLIS, March 8, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today announced that it will participate in the 28th Annual ROTH Conference on Tuesday, March 15 and Wednesday, March 16, 2016. Rob Kill, President and CEO, will meet with investors one-on-one at the conference and present at 10:00 a.m. Pacific Time on Wednesday, March 16 at the Ritz Carlton in Dana Point, CA.
Attendance at the conference is by invitation only. The investor presentation used at the conference will be posted to the investor section of the Company's website at ir.cogentixmedical.com under "Events & Presentations" on the day of the event.
About Cogentix Medical Cogentix Medical, Inc., headquartered in Minnetonka, Minnesota, with additional operations in New York, Massachusetts, The Netherlands and the United Kingdom, is a global medical device company. We design, develop, manufacture and market products for flexible endoscopy with our unique product lines featuring a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. We also commercialize the Urgent® PC Neuromodulation System, an FDA-cleared device that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). OAB is a chronic condition that affects approximately 42 million U.S. adults. The symptoms include urinary urgency, frequency and urge incontinence. We also offer Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on Cogentix Medical and our products, please visit us at www.cogentixmedical.com. 'CGNT-G'
For Further Information: EVC Group Doug Sherk/Brian Moore (Investors) 415-652-9100/310-579-6199
SOURCE Cogentix Medical, Inc.